Distinct Healthcare Holdings Limited (HKG:2677)
23.18
-0.46 (-1.95%)
Sep 2, 2026, 3:20 PM HKT
HKG:2677 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 1,151 | 1,065 | 958.58 | 690.44 | 473.18 | |
Revenue Growth | - | 11.05% | 38.84% | 45.91% | - |
Cost of Revenue | 837.31 | 797.49 | 732.58 | 556.93 | 429.2 |
Gross Profit | 313.86 | 267.04 | 226 | 133.5 | 43.98 |
Selling, General & Admin | 249.31 | 234.15 | 280.41 | 200.07 | 196.26 |
Research & Development | 12.15 | 4 | - | - | - |
Other Operating Expenses | 0.84 | -1.35 | -1.63 | -1.62 | -1.51 |
Operating Expenses | 264.3 | 238.79 | 279.93 | 198.75 | 194.8 |
Operating Income | 49.56 | 28.25 | -53.93 | -65.25 | -150.82 |
Interest Expense | -11.22 | -12.52 | -16.64 | -16.04 | -15.54 |
Interest & Investment Income | 5.03 | 2.48 | 8.62 | 10.15 | 1.17 |
Earnings From Equity Investments | - | - | -0.14 | - | - |
Currency Exchange Gain (Loss) | -1.49 | 0.41 | 5.23 | -2.95 | 2.35 |
Other Non Operating Income (Expenses) | 0.07 | 0.07 | -0.13 | 0.08 | -0.05 |
EBT Excluding Unusual Items | 41.95 | 18.69 | -56.99 | -74.02 | -162.89 |
Gain (Loss) on Sale of Investments | 6.06 | 4.28 | 8.68 | 7.17 | 9.36 |
Gain (Loss) on Sale of Assets | -6.12 | -5.11 | -3.24 | -1.03 | -1.83 |
Other Unusual Items | 111.9 | 118.07 | 131.31 | -294.32 | -83.97 |
Pretax Income | 153.79 | 135.93 | 79.74 | -362.19 | -239.33 |
Income Tax Expense | 14.42 | 4.48 | -0.48 | -8.95 | -17.81 |
Earnings From Continuing Operations | 139.37 | 131.45 | 80.23 | -353.25 | -221.52 |
Minority Interest in Earnings | 4.46 | 3.62 | 3.58 | 2.58 | 6.03 |
Net Income | 143.83 | 135.06 | 83.81 | -350.67 | -215.5 |
Net Income to Common | 143.83 | 135.06 | 83.81 | -350.67 | -215.5 |
Net Income Growth | - | 61.17% | - | - | - |
Shares Outstanding (Basic) | 32 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 58 | 55 | 54 | 14 | 14 |
Shares Change | 314.26% | 0.81% | 288.49% | - | - |
EPS (Basic) | 4.47 | 9.68 | 6.01 | -25.14 | -15.45 |
EPS (Diluted) | 0.60 | 0.31 | -0.83 | -25.14 | -15.45 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 172.25 | 162.33 | 113.37 | 57.4 | -79.9 |
Free Cash Flow Per Share | 2.98 | 2.97 | 2.09 | 4.12 | -5.73 |
Gross Margin | 27.26% | 25.09% | 23.58% | 19.34% | 9.29% |
Operating Margin | 4.30% | 2.65% | -5.63% | -9.45% | -31.87% |
Profit Margin | 12.50% | 12.69% | 8.74% | -50.79% | -45.54% |
Free Cash Flow Margin | 14.96% | 15.25% | 11.83% | 8.31% | -16.89% |
EBITDA | 110.29 | 88.67 | 5.87 | -9.31 | -105.55 |
EBITDA Margin | 9.58% | 8.33% | 0.61% | -1.35% | -22.31% |
D&A For EBITDA | 60.73 | 60.42 | 59.79 | 55.94 | 45.27 |
EBIT | 49.56 | 28.25 | -53.93 | -65.25 | -150.82 |
EBIT Margin | 4.30% | 2.65% | -5.63% | -9.45% | -31.87% |
Effective Tax Rate | 9.38% | 3.29% | - | - | - |